COMPANY

Dayi Therapeutics, Inc.

Location: New York, NY · source · Oct 15, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

NIH award NIH awarded $845K (STTR Phase II 5R42HD111138-03, continuation, notice May 11, 2026). NIH RePORTER 5R42HD111138-03 (May 11, 2026)
Evidence (1 event)
- May 11, 2026 · NIH RePORTER 5R42HD111138-03
  Organization: DAYI THERAPEUTICS, INC.; City/State: New York, NY; Project number: 5R42HD111138-03; Activity code: R42; Fiscal year: 2026; Award notice date: 2026-05-11; FY total cost (award amount): 845187; Administering IC: Eunice Kennedy Shriver National Institute of Child Health and Human Development; Project title: Developing RNA therapeutics for rare neurodevelopmental disorders; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

May 11, 2026 Grant Government grant — STTR: $845,187 (annual award, as published), announced May 11, 2026. Agency: NIH/NICHD. Source: government award database. source ↗
Dec 26, 2024 Grant Government grant — STTR: $853,987 (annual award, as published), announced Dec 26, 2024. Agency: NIH/NICHD. Source: government award database. source ↗

Last 2 years.

May 11, 2026 Government grant — STTR: $845,187 (annual award, as published), announced May 11, 2026. Agency: NIH/NICHD. Source: government award database. source ↗
Dec 26, 2024 Government grant — STTR: $853,987 (annual award, as published), announced Dec 26, 2024. Agency: NIH/NICHD. Source: government award database. source ↗